Filing Details
- Accession Number:
- 0001209191-12-007499
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-02-03 16:50:26
- Reporting Period:
- 2012-02-01
- Filing Date:
- 2012-02-03
- Accepted Time:
- 2012-02-03 16:50:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1088856 | Corcept Therapeutics Inc | CORT | Pharmaceutical Preparations (2834) | 770487658 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1286208 | L Robert Roe | C/O Corcept Therapeutics 149 Commonwealth Drive Menlo Park CA 94025 | President And Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-02-01 | 3,000 | $1.19 | 25,007 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-02-01 | 13,000 | $3.53 | 12,007 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-02-02 | 7,000 | $1.19 | 19,007 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-02-02 | 7,000 | $3.30 | 12,007 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock option | Disposition | 2012-02-01 | 3,000 | $0.00 | 3,000 | $1.19 |
| Common Stock | Stock option | Disposition | 2012-02-02 | 7,000 | $0.00 | 7,000 | $1.19 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 187,000 | 2019-03-26 | No | 4 | M | Direct | |
| 180,000 | 2019-03-26 | No | 4 | M | Direct |
Footnotes
- The sale is made pursuant to terms of a 10b5-1 plan in effect at the time of sale of the shares.
- Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $3.3627 to $3.60 per share. Full information on the numbers of shares sold at each sale price is available upon request.
- Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $3.2945 to $3.31 per share. Full information on the numbers of shares sold at each sale price is available upon request.
- Fully exerciseable.
Billionaire Hedge Funds
